Key Highlights

  • Maximus (NYSE:MMS) is calendared to report fiscal fourth-quarter 2026 results before the open on November 20, 2026, with EPS of USD 1.85 listed; no company date announcement was found.
  • Third-quarter adjusted EPS of USD 2.22 edged past a published consensus of USD 2.20, but Revenue of USD 1.28 billion missed about USD 1.32 billion and fell 5.1% year over year.
  • Fiscal 2026 adjusted EPS guidance was cut to USD 7.90 to USD 8.20 from USD 8.25 to USD 8.55, against USD 8.43 in published coverage, after a temporary contract modification.
  • Free Cash Flow was an outflow of USD 137 million in the third quarter, as Days Sales Outstanding reached 98, though USD 245 million was collected after quarter-end.

Calendar Lists November 20 and EPS of USD 1.85

Maximus (NYSE:MMS) is listed to report fiscal fourth-quarter 2026 results, for the quarter ended September 30, 2026, before the market opens on November 20, 2026. No company announcement of the date was found, so it comes from the calendar. The calendar's EPS of USD 1.85 is unverified as a consensus and no basis is stated, so the figure is shown with that caution. As a calculated cross-check, the full-year adjusted EPS guide of USD 7.90 to USD 8.20 less nine-month adjusted EPS of USD 6.14 implies a fourth quarter of about USD 1.76 to USD 2.06. The same arithmetic on revenue guidance of USD 5.2 billion to USD 5.35 billion less USD 3.93 billion implies about USD 1.27 billion to USD 1.42 billion. No implied move was found.

Third Quarter: Small EPS Beat, Revenue Miss and a Guidance Cut

For the quarter ended June 30, 2026, reported on August 6, 2026, adjusted EPS was USD 2.22 against USD 2.16 a year earlier and a published consensus of USD 2.20 (single-source), while GAAP EPS was USD 1.95. Revenue of USD 1.28 billion fell about 5% and missed about USD 1.32 billion, with management citing prior-year disaster work and temporary clinical Volume surges. Revenue guidance of USD 5.2 billion to USD 5.35 billion was kept, with results expected toward the lower end. Adjusted EPS guidance was lowered to USD 7.90 to USD 8.20, adjusted EBITDA Margin to about 13.7% from 14.2%, and free cash flow to USD 425 million to USD 475 million from USD 450 million to USD 500 million. No verified share-price reaction was found.

Federal Collections, Margins and U.S. Services Growth Decide the Read

The key issue for Maximus (NYSE:MMS) is cash conversion. Days sales outstanding, the average time to collect receivables, reached 98 because of delays at a major federal customer, producing a USD 137 million free cash outflow, and management said USD 245 million arrived after quarter-end. A fourth quarter that shows strong collections would ease worries, while a repeat would not. Second is margin: U.S. Federal Services margin rose to 18.6%, and the full-year guide for that segment is 16.5% to 17.0%. Third is U.S. Services, where revenue fell 4.9% and management expects positive organic growth by the fourth quarter. Signed awards were USD 1.25 billion year to date, and USD 1.35 billion more were awarded but unsigned. No analyst action from the past two weeks was verified.

Where Things Stand

It depends on collections. Maximus (NYSE:MMS) cut its adjusted EPS guide last quarter and burned USD 137 million of free cash flow, but also said USD 245 million was collected after quarter-end and that revenue would land toward the low end of its range, so the bar may be lower. The report is expected on November 20, 2026, before the open. Watch fourth-quarter cash flow, days sales outstanding, whether results fall within the implied EPS range of USD 1.76 to USD 2.06 (calculated), and the first fiscal 2027 outlook.